Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for ...

Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

Johnson & Johnson’s Stelara, Regeneron’s Eylea and Amgen’s Prolia are just some of the drugs facing off against new ...

In a report released today, David Amsellem from Piper Sandler maintained a Buy rating on Amneal Pharmaceuticals (AMRX – Research Report), with ...

BioMarin Pharmaceutical reported revenues of $747.3 million, up 15.6% year on year. This print exceeded analysts’ ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Investing.com -- Fitch Ratings has revised its outlook for biopharmaceutical company Amgen Inc (NASDAQ: AMGN ). to positive ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning ...

Akari Therapeutics ( ($AKTX) ) has issued an announcement. On March 14, 2025, Akari Therapeutics announced the appointment of Mr. Abizer ...